Brentuximab Vedotin

Brentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma. Reference standards of Brentuximab Vedotin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Brentuximab vedotin
    [catalogue_number] => PA 02 2740000
    [category_ids] => ,78,70,82,170,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => 914088-09-8
    [pslug] => 914088-09-8-brentuximab-vedotin-pa022740000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 2740000

Brentuximab vedotin


  • Catalogue No.:PA 02 2740000

  • CAS :

    914088-09-8

  • Molecular Formula : NA

  • Molecular Weight : NA

CPHI INDIA- 28, 30 November